Vanda Loses US Trade Secrets Battle Over Fanapt And Hetlioz Generics

 
• By Dean Rudge

“While Vanda developed the brand-name drugs, the trade secret and confidential and proprietary information claimed to have been taken by the government was, in fact, proposed and recommended to Vanda by the FDA,” a US federal court said.

trade secrets
The federal court said the dissolution specifications adopted by generics firms were not developed by Vanda. • Source: Shutterstock

More from Litigation

More from Legal & IP